In the last three years, Colgate Palmolive (India) Limited has gone through the tough period. The company had lost its market share and became a slow mover stock for investors. It is now planning to see a double-digit growth in its topline led by volume sales.
As per the ORG-Marg estimates, Rs 10 bn toothpaste market had reported a negative growth in FY00. The penetration of toothpaste in India is still less than 30%. The market is growing at a slower pace and in the past few years growth rate is further impacted due to continuous increase in the prices and increasing competition. Colgate is the leader in the market with 50% share and its close competitor HLL commands a 35% market share.
As can be seen from the table below, in FY00, Colgate has successfully grown its volume sales and has also effected a price increase of around 8% in soaps and toilet preparations segment which contribute the major portion of total sales. The company would continue with its strategy of growing topline boosted by volumes by introducing new products and re-launching some of the successful brands. During the year, the company has re-launched Colgate Dental Cream and Colgate Fresh Energy Gel. It will also continue its focus on Colgate Total, Sensation Whitening and Cibaca. Concentration on the volumes could only drive the growth in this price sensitive market.
Soaps, Cosmetics and Toilet Preparation
Sales Qty (m)
Sales (Rs m)
Tooth Brushes & Shave Brushes
At the current market price of Rs 160, Colgate is available at a P/E of 42 times its FY00 earnings and 37 times its projected FY01 earnings. Its market cap to sales ratio of 1.9 times suggests that its long-term growth is a concern, as the market growth remains low and the competition intensifies. The perception about the stock is likely to change gradually with improved financial performance and aggressive strategies implemented by the company.
LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA or Canada, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.
Equitymaster Agora Research Private Limited. 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India. Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: email@example.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407